CHANGES IN THE PARAMETERS OF THE HEMOSTATIC SYSTEM IN THE TREATMENT OF TRIGEMINAL NEURALGIA WITH BIOREGULATORY PEPTIDES

Katman M., Yashnova N., Golikova D.

According to foreign and domestic authors, the incidence of trigeminal neuralgia ranges from 3 to 5 cases per 100,000 population per year. At the same time, this pathology occurs more often in women than in men in a ratio of 6:4, aged 40 years and older. Trigeminal neuralgia (TN) is a disease characterized by a severe, recurrent course and limited effective treatment methods, which significantly affects the patient's quality of life. There are a number of scientific studies that speak about the effective effect of bioregulatory therapy on the immune system, hemostasis and nonspecific resistance.

Keywords:trigeminal neuralgia, bioregulatory therapy, hemostasis, cortexin, surgical dentistry